| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
8-K: Submission of Matters to a Vote of Security Holders
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DUBLIN, Ohio, November 5, 2026 - Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2027 revenues of $67.5 billion, an increase of 5% from the first quarter of fiscal year 2026. First quarter GAAP operating earnings inc... |
| 01 Oct 2026 |
8-K: Regulation FD Disclosure
DUBLIN, Ohio, October 1, 2026 – Cardinal Health (NYSE: CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the continuat... |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DUBLIN, Ohio, August 11, 2026 – Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2026 revenues of $63.7 billion, an increase of 6% from the fourth quarter of fiscal year 2025. Fourth quarter GAAP operating earnings i... |
| 11 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
as the Administrative Agent, the Swingline Lender and an LC Issuer |
| 05 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 4, 2026, Cardinal Health, Inc. (the “Company”) appointed Anita Zielinski as its Chief Accounting Officer of the Company, effective November 5, 2026. Ms. Zielinski will succeed Mary Scherer, who will continue to serve as Chief A... |
| 30 Apr 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DUBLIN, Ohio, April 30, 2026 – Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025. |
| 23 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
DUBLIN, Ohio, March 23, 2026 — Cardinal Health (NYSE: CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny’s retirement, effective... |
| 05 Mar 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On March 2, 2026, Mary Scherer, Senior Vice President and Chief Accounting Officer, notified Cardinal Health, Inc. (the “Company”) that she intends to retire in February 2027. The Company will initiate a search process to identify her su... |
| 05 Feb 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DUBLIN, Ohio, February 5, 2026 – Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings... |
| 13 Jan 2026 |
8-K: Regulation FD Disclosure
Cardinal Health Raises Fiscal 2026 Outlook and Highlights Strategic Progress During J.P. Morgan Healthcare Conference Presentation |
| 06 Nov 2025 |
8-K: Submission of Matters to a Vote of Security Holders
Cardinal Health, Inc. (the "Company") held its 2025 Annual Meeting of Shareholders (the "Annual Meeting") on November 5, 2025. See the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Com... |
| 30 Oct 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DUBLIN, Ohio, October 30, 2025 - Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2026 revenues of $64 billion, an increase of 22% from the first quarter of fiscal year 2025. First quarter GAAP operating earnings incr... |
| 10 Oct 2025 |
8-K: Entry into a Material Definitive Agreement
2.6 Facility Fee; Other Fees; Reductions in Aggregate Commitment. 24 |
| 03 Oct 2025 |
8-K: Entry into a Material Definitive Agreement
This FIRST AMENDMENT TO THE FIFTH AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (this “Amendment”), dated as of September 30, 2025, is entered into by and among the following parties: |
| 27 Aug 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
THIRD SUPPLEMENTAL INDENTURE, dated as of August 27, 2025 (the “Third Supplemental Indenture”), between Cardinal Health, Inc., an Ohio corporation (the “Issuer”), and The Bank of New York Mellon Trust Company, N.A., a national banking as... |
| 14 Aug 2025 |
8-K: Other Events
Cardinal Health, Inc., an Ohio corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule II hereto (the “Underwriters”), the respective amounts set forth in Schedule II of (i) $600,000,000 aggregate pr... |
| 12 Aug 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DUBLIN, Ohio, August 12, 2025 – Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat to the fourth quarter of fiscal year 2024. Fourth quarter revenue increased 21% excludi... |
| 12 Jun 2025 |
8-K: Regulation FD Disclosure
DUBLIN, Ohio, June 12, 2025 – Cardinal Health (NYSE: CAH) today will host an Investor Day beginning at 9:00 a.m. ET, where management will detail its growth strategies to maximize the company’s potential for all stakeholders. |
| 01 May 2025 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
DUBLIN, Ohio, May 1, 2025 – Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2025 revenues of $54.9 billion, flat to the third quarter of fiscal year 2024. Third quarter revenue increased 19% excluding the impact of t... |
Loading...